Skip to content

Sonographic Evaluation of the Single-incision Needleless (Contasure-needleless®) Mini-sling Placement to Predict Success

Sonographic Evaluation of the Single-incision Needleless (Contasure-needleless®) Mini-sling Placement to Predict Success

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03763097
Enrollment
64
Registered
2018-12-04
Start date
2018-11-26
Completion date
2019-04-21
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence,Stress

Keywords

pelvic floor ultrasonography, transperineal ultrasound, introital ultrasound, mini-sling, needleless, Urinary Incontinence,Stress

Brief summary

Transperineal ultrasonography is gaining importance in preoperative and postoperative evaluation of the patient with urinary incontinence with allowing well detailed information about the anterior compartment. There is little evidence that transperineal sonography can aid surgeons to predict the success or failure after mid-urethral slings. We aimed to investigate the efficacy of sonography in mini-sling operations to predict the success or failure.

Detailed description

Women who are scheduled for anti-incontinence operation due to their stress urinary incontinence will be pre- and postoperatively evaluated by transperineal and introital ultrasound. Patients will be followed for at least 1 year.

Interventions

Pelvic floor ultrasound will include transperineal and introital ultrasound

Sponsors

Bartin State Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with clinically stress urinary incontinence * Patients who claim that their condition severely impair their quality of life * Patients who are failed on conservative management (life style changes and pelvic floor exercises)

Exclusion criteria

* Patients who have unregulated diabetes mellitus (they will be included after appropriate and sustainable blood glucose regulation) * Patients who have neurological condition that may affect the incontinence * Patients who have psychiatric disease that may affect the subjective evaluation.

Design outcomes

Primary

MeasureTime frameDescription
The correlation of failure with the sonographic features of the meshEvaluation at postoperative 1st and 4th weeksPatients will be accepted as failure if their stress test is positive Sonographic features of the mesh includes the shape of the mesh, the distance to the mid-urethra, the position related to the proximal urethra and the angle between the mesh arms on coronal axis

Secondary

MeasureTime frameDescription
NocturiaEvaluation at postoperative 1st and 4th weeks and preoperativelyThe nocturia episodes will be evaluated by a non-validated Likert scale (between 0-3). Minimum and minimum scores are between 0 and 3. 0 will mean no episode of urinating during the sleep. 1 will mean one episode of nocturia. 2 will mean two episodes of nocturia. 3 will mean three or more episodes of nocturia. Higher values represent worse outcome.
Urge symptomsEvaluation at postoperative 1st and 4th weeks and preoperativelyMichigan Incontinence Severity Index (M-ISI) scale will be used to assess subjective outcome including urge symptoms. This scale has ten items, consisting of a total M-ISI domain (the sum of items 1-8) and a distinct Bother domain (the sum of items 9 and 10). The total M-ISI score consists of three subdomains (items 1-3 for stress urinary incontinence \[SUI\], items 4-6 for urge urinary incontinence \[UUI\], and items 7 and 8 for Pad usage \[PU\]. The responses for each item range from 0 to 4 on a Likert-type scale, with higher values representing greater symptoms and greater bother. Total domain and subdomain scores are obtained by simply adding the respective answers. The minimally important difference has been determined for the following domains/subdomains: total M-ISI (4 points), SUI (2 points), UUI (2 points), and PU (1 point).
Subjective successEvaluation at postoperative 1st and 4th weeksPatient Global Improvement of Improvement will be used to assess the subjective success
POP-QEvaluation at postoperative 1st and 4th weeks and preoperativelyPOP-Q measurements will be assessed to measure the pelvic floor prolapse if exist
Anterior compartment mobility distancesEvaluation at postoperative 1st and 4th weeks and preoperativelyOn maximal Valsalva maneuver: Bladder neck descent (mm), pubourethral distance (mm), urethral thickness (mm, measured at proximal, mid and distal portions) and urethral length (mm)
Anterior compartment mobility anglesEvaluation at postoperative 1st and 4th weeks and preoperativelyOn maximal Valsalva maneuver: Proximal urethral rotation (degree), retrovesical angle (degree)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026